Patent Endometriosis

Automatically clustered newsroom coverage around one of the most active themes in the intellectual property ecosystem.

TrademarksGlobal

Proteomics International Secures US Patent for Endometriosis Diagnostic Test Valid Through 2041

Proteomics International Laboratories (ASX:PIQ) has been awarded a United States patent for its innovative PromarkerEndo blood test for diagnosing endometriosis. The patent, valid until March 2041, enhances the company’s intellectual property portfolio and supports its global commercialisation strategy, particularly i…

Wednesday, July 8, 2026

Newsletters & Digests

Follow Patent Endometriosis

Subscribe to receive daily and weekly newsroom coverage aligned to this trend cluster and adjacent IP developments.

Explore

All newsroom coverage Filtered archive